Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2023 1
2024 7

Search Results

8 results

Results by year

Filters applied: . Clear all
Page 1
Edoxaban, Rivaroxaban, or Apixaban for Cancer-Associated Venous Thromboembolism in the Real World: Insights from the COMMAND VTE Registry-2.
Sueta D, Yamashita Y, Morimoto T, Chatani R, Nishimoto Y, Kaneda K, Ikeda N, Kobayashi Y, Ikeda S, Kim K, Inoko M, Takase T, Tsuji S, Oi M, Takada T, Otsui K, Sakamoto J, Ogihara Y, Inoue T, Usami S, Chen PM, Togi K, Koitabashi N, Hiramori S, Doi K, Mabuchi H, Tsuyuki Y, Murata K, Takabayashi K, Nakai H, Shioyama W, Dohke T, Nishikawa R, Kimura T, Tsujita K; COMMAND VTE Registry-2 Investigators. Sueta D, et al. Thromb Haemost. 2024 May 24. doi: 10.1055/a-2316-5269. Online ahead of print. Thromb Haemost. 2024. PMID: 38684190
Cancer-associated venous thromboembolism in the direct oral anticoagulants era: Insight from the COMMAND VTE Registry-2.
Chatani R, Yamashita Y, Morimoto T, Mushiake K, Kadota K, Kaneda K, Nishimoto Y, Ikeda N, Kobayashi Y, Ikeda S, Kim K, Inoko M, Takase T, Tsuji S, Oi M, Takada T, Otsui K, Sakamoto J, Ogihara Y, Inoue T, Usami S, Chen PM, Togi K, Koitabashi N, Hiramori S, Doi K, Mabuchi H, Tsuyuki Y, Murata K, Takabayashi K, Nakai H, Sueta D, Shioyama W, Dohke T, Nishikawa R, Kimura T; COMMAND VTE Registry-2 Investigators. Chatani R, et al. Thromb Res. 2024 Feb;234:86-93. doi: 10.1016/j.thromres.2023.12.016. Epub 2024 Jan 2. Thromb Res. 2024. PMID: 38190788
Anticoagulation strategies and long-term recurrence in patients with venous thromboembolism in the era of direct oral anticoagulants.
Kaneda K, Yamashita Y, Morimoto T, Chatani R, Nishimoto Y, Ikeda N, Kobayashi Y, Ikeda S, Kim K, Inoko M, Takase T, Tsuji S, Oi M, Takada T, Otsui K, Kimura T; COMMAND VTE Registry-2 Investigators. Kaneda K, et al. Eur J Intern Med. 2023 Dec;118:59-72. doi: 10.1016/j.ejim.2023.08.007. Epub 2023 Aug 11. Eur J Intern Med. 2023. PMID: 37574348 Free article.
External validation of the PE-SARD bleeding score for early major bleeding in patients with acute pulmonary embolism: From the COMMAND VTE Registry-2.
Nishimoto Y, Yamashita Y, Morimoto T, Chatani R, Kaneda K, Ikeda N, Kobayashi Y, Ikeda S, Kim K, Inoko M, Takase T, Tsuji S, Oi M, Takada T, Otsui K, Sakamoto J, Ogihara Y, Inoue T, Usami S, Chen PM, Togi K, Koitabashi N, Hiramori S, Doi K, Mabuchi H, Tsuyuki Y, Murata K, Takabayashi K, Nakai H, Sueta D, Shioyama W, Dohke T, Nishikawa R, Sato Y, Watanabe T, Yamada T, Fukunami M, Kimura T; COMMAND VTE Registry-2 Investigators. Nishimoto Y, et al. J Thromb Haemost. 2024 Jun 27:S1538-7836(24)00369-6. doi: 10.1016/j.jtha.2024.06.011. Online ahead of print. J Thromb Haemost. 2024. PMID: 38944241
Fragility and long-term clinical outcomes in patients with venous thromboembolism receiving direct oral anticoagulants: From the COMMAND VTE REGISTRY-2.
Ogihara Y, Yamashita Y, Morimoto T, Chatani R, Kaneda K, Nishimoto Y, Ikeda N, Kobayashi Y, Ikeda S, Kim K, Inoko M, Takase T, Tsuji S, Oi M, Takada T, Otsui K, Sakamoto J, Inoue T, Usami S, Chen PM, Togi K, Koitabashi N, Hiramori S, Doi K, Mabuchi H, Tsuyuki Y, Murata K, Takabayashi K, Nakai H, Sueta D, Shioyama W, Dohke T, Sato T, Nishikawa R, Kimura T, Dohi K; COMMAND VTE Registry-2 Investigators. Ogihara Y, et al. Thromb Res. 2024 Apr;236:191-200. doi: 10.1016/j.thromres.2024.02.023. Epub 2024 Feb 29. Thromb Res. 2024. PMID: 38461613
Transition of management strategies and long-term outcomes in cancer-associated venous thromboembolism from the warfarin era to the direct oral anticoagulant era.
Chatani R, Yamashita Y, Morimoto T, Kaneda K, Mushiake K, Kadota K, Nishimoto Y, Ikeda N, Kobayashi Y, Ikeda S, Kim K, Inoko M, Takase T, Tsuji S, Oi M, Kimura T; COMMAND VTE Registry-2 Investigators. Chatani R, et al. Eur J Intern Med. 2024 May;123:72-80. doi: 10.1016/j.ejim.2024.01.012. Epub 2024 Jan 25. Eur J Intern Med. 2024. PMID: 38278660
Direct oral anticoagulant-associated bleeding complications in patients with gastrointestinal cancer and venous thromboembolism.
Nishimoto Y, Yamashita Y, Morimoto T, Chatani R, Kaneda K, Ikeda N, Kobayashi Y, Ikeda S, Kim K, Inoko M, Takase T, Sato Y, Watanabe T, Yamada T, Fukunami M, Kimura T; COMMAND VTE Registry-2 Investigators. Nishimoto Y, et al. Eur J Intern Med. 2024 Apr 24:S0953-6205(24)00171-7. doi: 10.1016/j.ejim.2024.04.012. Online ahead of print. Eur J Intern Med. 2024. PMID: 38664165